Active Bacterial Myocarditis: A Case Report and Review of the Literature

Journal of Heart and Lung Transplantation

Volumn 26, Issue 7, 2007, Pages 745-749

  Haddad, François ^a   Berry, Gerald ^a   Doyle, Ramona L ^a   Martineau, Pierre ^a   Leung, Tack Ki ^a   Racine, Normand ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CARVEDILOL; DOPAMINE; ENALAPRIL; HYPERTENSIVE FACTOR; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN; WARFARIN;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL MYOCARDITIS; BLOOD CULTURE; CASE REPORT; DETERIORATION; ELECTROCARDIOGRAPHY; FEMALE; HEART MUSCLE BIOPSY; HEMODYNAMICS; HUMAN; IMMUNOCOMPETENCE; LISTERIA MONOCYTOGENES; MYOCARDITIS; PRIORITY JOURNAL; TISSUE CULTURE;

ANTI-BACTERIAL AGENTS; FEMALE; HEART; HUMANS; LISTERIA INFECTIONS; LISTERIA MONOCYTOGENES; MIDDLE AGED; MYOCARDITIS; NECROSIS; VENTRICULAR DYSFUNCTION; VENTRICULAR REMODELING;

EID: 34347253868     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2007.04.010     Document Type: Article

References (23)

1. Kuhl U., Pauschinger M., Seeberg B., et al. Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation 112 (2005) 1965-1970
2. Wasi F., and Shuter J. Primary bacterial infection of the myocardium. Front Biosci 8 suppl (2003) s228-s231
3. Lorber B. Listeriosis. Clin Infect Dis 24 (1997) 1-9
4. Lorber B. Listeria monocytogenes. Principles and practice of infectious disease. 6th ed (2005), Elsevier, Amsterdam 2477-2484
5. Stamm A.M., Smith S.H., Kirklin J.K., and McGiffin D.C. Listerial myocarditis in cardiac transplantation. Rev Infect Dis 12 (1990) 820-823
6. Mason J.W., Stinson E.B., Hunt S.A., Schroeder J.S., and Rider A.K. Infections after cardiac transplantation: relation to rejection therapy. Ann Intern Med 85 (1976) 69-72
7. McCue M.J., and Moore E.E. Myocarditis with microabscess formation caused by Listeria monocytogenes associated with myocardial infarct. Hum Pathol 10 (1979) 469-472
8. Maeder M., Fehr T., Rickli H., and Ammann P. Sepsis-associated myocardial dysfunction: diagnostic and prognostic impact of cardiac troponins and natriuretic peptides. Chest 129 (2006) 1349-1366
9. Charpentier J., Luyt C.E., Fulla Y., et al. Brain natriuretic peptide: a marker of myocardial dysfunction and prognosis during severe sepsis. Crit Care Med 32 (2004) 660-665
10. Parker M.M., Shelhamer J.H., Natanson C., Alling D.W., and Parrillo J.E. Serial cardiovascular variables in survivors and nonsurvivors of human septic shock: heart rate as an early predictor of prognosis. Crit Care Med 15 (1987) 923-929
11. Parker M.M., McCarthy K.E., Ognibene F.P., and Parrillo J.E. Right ventricular dysfunction and dilatation, similar to left ventricular changes, characterize the cardiac depression of septic shock in humans. Chest 97 (1990) 126-131
12. Mendes L.A., Picard M.H., Dec G.W., Hartz V.L., Palacios I.F., and Davidoff R. Ventricular remodeling in active myocarditis. Myocarditis treatment trial. Am Heart J 138 (1999) 303-308
13. Skouri H.N., Dec G.W., Friedrich M.G., and Cooper L.T. Noninvasive imaging in myocarditis. J Am Coll Cardiol 48 (2006) 2085-2093
14. Aretz H.T., Billingham M.E., Edwards W.D., et al. Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol 1 (1987) 3-14
15. Berry G.J., and Atkins K.A. Pathology of human myocarditis. In: Cooper L.T. (Ed). Myocarditis: from bench to bedside (2003), Humana Press, Totowa, NJ 325-370
16. Annane D., Sebille V., Charpentier C., et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288 (2002) 862-871
17. Bernard G.R., Vincent J.L., Laterre P.F., et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344 (2001) 699-709
18. Hunt S.A. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 46 (2005) e1-e82
19. Baugman K.L., and Wynne J. Myocarditis. In: Braunwald E., Zipes D., Libby P., and Bonow R. (Eds). Braunwald's heart disease. 7th ed (2005), Saunders, Philadelphia 1706-1707
20. Giuliani E.R., Gerch B.J., McGoon M.D., and Schaff H.V. Mayo Clinic practical cardiology. 3rd ed (1996), Mosby, St. Louis
21. Doyle A., Bhalla K.S., Jones III J.M., and Ennis D.M. Myocardial involvement in Rocky Mountain spotted fever: a case report and review. Am J Med Sci 332 (2006) 208-210
22. Kotilainen P., Lehtopolku M., and Hakanen A.J. Myopericarditis in a patient with Campylobacter enteritis: a case report and literature review. Scand J Infect Dis 38 (2006) 549-552
23. Paz A., and Potasman I. Mycoplasma-associated carditis. Case reports and review. Cardiology 97 (2002) 83-88